z-logo
Premium
The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction
Author(s) -
Bataller Luis,
Wade Deborly F.,
Graus Francesc,
Rosenfeld Myrna R.,
Dalmau Josep
Publication year - 2003
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.10434
Subject(s) - cerebellum , zinc finger , medicine , paraneoplastic cerebellar degeneration , epitope , antibody , disease , immune system , immunology , cancer research , biology , gene , transcription factor , autoantibody , genetics
Probing a cerebellar expression library with TrAb sera from patients with Hodgkin's disease and paraneoplastic cerebellar degeneration resulted in the isolation of MAZ ( myc ‐associated zinc‐finger protein). Eleven of 19 TrAb sera and 16 of 131 controls reacted with MAZ, indicating a significant, although not specific, association between Tr and MAZ immunities ( p < 0.001). Interestingly, 9 of 16 positive control patients also had cerebellar dysfunction. Purified MAZ antibodies reacted with Purkinje cells. In neuronal cells, MAZ interacts with DCC ( Deleted in Colorectal Cancer product), the receptor for netrin‐1, a neuronal survival factor. These findings suggest epitope spreading between the Tr antigen and the MAZ–DCC complex and offer a possible model of immune‐mediated cerebellar disease. Ann Neurol 2003;53:000–000

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom